600594 益佰制药
2026/09 - 九个月
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资34,717-0.24%34,80235,10135,07135,413
投资性房地产0--0000
固定资产1,356,630-6.13%1,445,2081,602,5461,705,6851,639,762
在建工程2,83930.17%2,1816994,988145,942
无形资产302,079-3.27%312,294319,558330,887362,032
商誉0--0131,263164,038164,038
其他非流动资产200,3850.38%199,633260,507287,437299,211
1,896,650-4.89%1,994,1182,349,6752,528,1062,646,398

流动资产
货币资金402,689-9.94%447,133521,007699,469592,355
应收账款128,395-23.27%167,338191,361227,056294,527
存货495,019-9.49%546,903607,775586,651625,085
其他流动资产237,481-17.06%286,345429,882555,973528,664
1,263,584-12.72%1,447,7181,750,0262,069,1482,040,631

流动负债
短期借款408,870-1.22%413,928380,929446,045537,110
应付票据0--0000
应付帐款61,053-40.72%102,986124,483135,058149,428
其他流动负债348,233-11.16%391,961443,600348,487486,178
818,156-9.98%908,875949,012929,5901,172,715
流动资产净值445,428-17.34%538,842801,0141,139,558867,916
资产总额减流动负债2,342,078-7.54%2,532,9603,150,6893,667,6643,514,314

非流动负债
长期借款85,706-14.41%100,139307,517387,225343,038
应付债券0--0000
其他非流动负债140,011-13.69%162,217237,062262,185164,034
225,717-13.97%262,356544,578649,409507,073

总权益
    实收股本784,394-0.95%791,927791,927791,927791,927
    储备项目1,252,137-10.30%1,395,8591,697,8312,092,5172,069,462
股东权益2,036,531-6.91%2,187,7872,489,7582,884,4442,861,389
非控股权益79,830-3.61%82,817116,352133,810145,852